Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
Journal article
Zhou Y. and Jiang S., (2023), Pathogens, 12, 817 - 817
Editorial: Peptide-based immunotherapy against emerging viral infections.
Journal article
Jiang S., (2023), Front Immunol, 14
HIV associated cell death: Peptide-induced apoptosis restricts viral transmission.
Journal article
Chen Q. et al, (2023), Front Immunol, 14
Survivin-Based Recombinant Overlapping Peptides Induce T Lymphocyte Cytotoxicity and Prolong the Survival in In Vivo Melanoma Model
Journal article
Zhang Y. et al, (2023), Advanced Therapeutics
Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines.
Journal article
Jiang S. et al, (2022), Front Immunol, 13
In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10.
Journal article
Zhang Q. et al, (2022), Front Immunol, 13
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Journal article
Stephens AJ. et al, (2021), Frontiers in Immunology, 12
Survivin as a Biological Biomarker for Diagnosis and Therapy.
Journal article
Li Y. et al, (2021), Expert Opin Biol Ther
HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study.
Journal article
Zhang L. et al, (2021), Front Immunol, 12
TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.
Journal article
Lu W. et al, (2019), Clin Exp Immunol
ANTIBODY FACILITATING PROGRAMMED NECROSIS OF CELLS AND APPLICATION THEREOF
Patent
JIANG S. and Lu W., (2018)
PROTEIN FOR NEUTRALIZING PROGRAMMED NECROCYTOSIS PROMOTION ANTIBODY, AND APPLICATION OF PROTEIN
Patent
JIANG S. and Lu W., (2018)
Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins.
Journal article
Cai L. et al, (2017), Oncotarget, 8, 76516 - 76524
ARTIFICIAL MULTI-ANTIGEN FUSION PROTEIN AND PREPARATION AND USE THEREOF
Patent
JIANG S. et al, (2017)
Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
Journal article
Tchilian E. et al, (2013), Vaccine, 31, 4624 - 4631
TNF-alpha short peptide- related to apoptosis or necrosis and applications thereof
Patent
JIANG S., (2012)
Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.
Journal article
Hong H. et al, (2010), Clin Exp Immunol, 159, 93 - 99
Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells.
Journal article
Zhang H. et al, (2009), J Biol Chem, 284, 9184 - 9191